Regulatory T cells and Disease damage in systemic lupus erythematosus

CD5+ B Lymphocytes in Systemic Lupus Erythematosus Patients: Relation to Disease Activity

CD5+ B Lymphocytes in Systemic Lupus Erythematosus Patients: Relation to Disease Activity

Tumor Necrosis Factor-Related Apoptosis Inducing Ligand in Systemic Lupus Erythematosus Patients; Potential Role in Disease Activity, Neutropenia and Renal Impairment

Dysregulation of Tumor Necrosis Factor Alpha-Induced Protein 3 mRNA Expression in Lupus Nephritis in Relation to Clinic-pathologic Characteristics and Disease Activity of Systemi

TOLL-LIKE RECEPTORS 4 AND 9 EXPRESSION IN SYSTEMIC LUPUS ERYTHEMATOSUS AND DERMATOMYOSITIS: RELATION TO CLINICAL STATUS AND DISEASE ACTIVITY

T-cell markers in systemic lupus erythromatosus patients

Circulating CD19 CD24hi CD38hi Regulatory B Cells Percentage in Lupus Nephritis Patients: Does It Differ?

T-lymphocyte subsets (CD3+, CD4+, and CD8+) in Systemic Lupus Erythematosus (SLE): Correlation with Clinical Manifestation

T Helper 17 Cells and Inducible Nitric Oxide Synthase: Good Index to Predict Renal Tissue Involvement in Systemic Lupus Erythematosus Patients